Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bain Capital
MedTech
Medtech M&A, VC funding slowed in H1 2023: Evaluate
After experiencing a boom in 2021 to make up for 2020's dearth of dealmaking, medtech M&A and VC deals have been on a steady downward slope.
Andrea Park
Jul 10, 2023 10:19am
Cerevel to change up CEO as 7 data readouts near showdown
May 3, 2023 6:30am
JenaValve nabs $100M to clear TAVR system’s FDA pathway
Aug 31, 2022 3:35pm
Olympus inks $3B sale of scientific tools unit to Bain Capital
Aug 29, 2022 10:19am
Takeda-backed cardiovascular biotech nabs $300M from Bain
Oct 27, 2021 12:05pm
Going big: Bain reels in $1.9B for more mammoth biotech bets
Aug 17, 2021 7:30am